If confirmed as the HHS Secretary by the US Senate, RFK Jr will oversee federal agencies that dictate healthcare policy in ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’s therapy Leqembi for a subgroup of patients.

Flagship Pioneering -founded Valo Health has announced the appointment of Dr Brian Alexander as its new CEO. Additionally, ...

Developed in partnership with CRScube, a renowned South Korean clinical research technology provider, the purpose-built new ...

Discover the top sales and marketing intelligence solutions tailored for the pharmaceutical industry. Download our guide to predictive analytics and data-driven insights.

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

In Shanghai, more than 300 industry leaders, experts, and partners met to discuss the latest trends in the data centre ...

BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a ...

The US Food and Drug Administration (FDA) has granted accelerated approval for PTC Therapeutics’ KEBILIDI, the first gene ...